Cite
Vogel C, Cobleigh MA, Tripathy D, et al. First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. a preliminary report. Eur J Cancer. 2001;37:25-29
Vogel, C., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., Shak, S., & Stewart, S. J. (2001). First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. a preliminary report. European journal of cancer (Oxford, England : 1990), 3725-29.
Vogel, C, et al. "First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. a preliminary report." European journal of cancer (Oxford, England : 1990) vol. 37 (2001): 25-29.
Vogel C, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ. First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. a preliminary report. Eur J Cancer. 2001 Jan;37:25-29. PMID: 11342197.
Copy
Download .nbib